Skip to content
Advertisement

Unlearn.AI generates AI digital twins – individualized predictions of disease progression from models trained on historical clinical trial data – for use as synthetic control arms via its EMA-qualified PROCOVA methodology, reducing the number of patients trials need to randomize to a control group.

Tabular
Advertisement